Results 161 to 169 of about 6,049 (169)

Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data

European Heart Journal, 2019
Jasvinder Singh, John D Cleveland
exaly  

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2019
Cheng-Wei Liu, Fu-Shun Hsu
exaly  

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout

Seminars in Arthritis and Rheumatism, 2013
Joanne Homik, Marcello Tonelli, Natasha Wiebe   +2 more
exaly  

An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia

International Journal of Rheumatic Diseases, 2014
Anbin Huang, Xinfang Huang
exaly  

A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

International Journal of Rheumatic Diseases, 2015
Yongde Peng, Qiuhe Ji, Xiangyang Liu
exaly  

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

Life Sciences, 2005
exaly  

Febuxostat suppressed renal ischemia–reperfusion injury via reduced oxidative stress

Biochemical and Biophysical Research Communications, 2012
Hiromi Rakugi, Jun-Ya Kaimori, Yoshitaka Isaka   +2 more
exaly  

Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout

Drugs, 2015
exaly  

Pharmacokinetic Interactions of Concomitant Administration of Febuxostat and NSAIDs

Journal of Clinical Pharmacology, 2006
Reza Khosravan, Nancy Joseph-Ridge, Laurent Vernillet   +2 more
exaly